In the News | Friends of Cancer Research

You are here

In the News

February 1, 2019
Easing comorbid-condition exclusion criteria could significantly increase participation in clinical trials for cancer, researchers report.   "Some eligibility exclusions for comorbid conditions will... Read more
January 31, 2019
A pair of former FDA commissioners debated whether FDA should take the lead on using real-world data and real-world evidence to determine the actual value of drug therapies and in turn ensure the... Read more
January 29, 2019
Stressing the need for speed and efficiency, FDA Commissioner Scott Gottlieb on Monday offered a look at FDA’s plans around real-world data (RWD) and real-world evidence (RWE) in 2019.   The speech... Read more
January 29, 2019
Randomized controlled clinical trials are a great way to test the safety and effectiveness of a new drug. But when the trial is over and the drug approved, it’s used by patients and health care... Read more
January 29, 2019
SWOG's Lung Cancer Master Protocol (Lung-MAP) precision medicine trial is implementing new protocols and expanding to include all advanced stage non-small cell lung cancer patients, moving beyond its... Read more
January 29, 2019
Real-world evidence (RWE) or real-world data (RWD) relates to the collection of information about a drug’s safety and efficacy outside the structure of a clinical trial. Speaking yesterday at the... Read more
January 29, 2019
The Lung Cancer Master Protocol, or Lung-MAP, will expand to include all patients diagnosed with non-small cell lung cancer.   Lung-MAP — the first large-scale precision medicine lung cancer trial... Read more
January 29, 2019
Washington, DC – The Lung Cancer Master Protocol (Lung-MAP), the first precision medicine trial in lung cancer supported by the National Cancer Institute (NCI), part of the National Institutes of... Read more
January 21, 2019
In an effort to ensure that study participants are more reflective of real-world populations, the National Cancer Institute (NCI) has revised its clinical trial protocols to expand access for... Read more
January 17, 2019
Friends Welcomes Margaret Anderson, Edward J. Benz Jr, and Elizabeth Thompson January 17, 2019 – Washington, DC – Friends of Cancer Research (Friends) is pleased to announce the additions of Margaret... Read more

Pages